Valuation: HANDOK Inc.

Market Cap 108B 80.44M 72.32M 67.49M 61.17M 115M 7.65B 116M 810M 316M 3.97B 302M 295M 12.78B P/E 2024
-3.16x
P/E 2025 -69x
Enterprise Value 458B 342M 307M 287M 260M 488M 32.51B 491M 3.44B 1.34B 16.87B 1.28B 1.25B 54.26B EV / Sales 2024
0.95x
EV / Sales 2025 0.93x
Free-Float
52.22%
Yield 2024
1.66%
Yield 2025 -
1 day+1.84%
1 week-2.58%
Current month-1.42%
1 month-12.16%
3 months+6.54%
6 months-18.85%
Current year-25.80%
1 week 8,000
Extreme 8000
8,750
1 month 8,000
Extreme 8000
9,440
Current year 6,460
Extreme 6460
11,820
1 year 6,460
Extreme 6460
12,150
3 years 6,460
Extreme 6460
20,300
5 years 6,460
Extreme 6460
24,800
10 years 6,460
Extreme 6460
44,750
Manager TitleAgeSince
Chief Executive Officer 69 -
Chief Executive Officer 68 01/01/1996
Director of Finance/CFO 58 -
Director TitleAgeSince
Chairman 68 01/01/1996
Director/Board Member 69 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%-2.58%-29.28%-33.73% 79M
+3.62%+4.43%+47.52%+98.41% 1,040B
+2.13%-0.34%+33.01%+61.88% 599B
+3.32%+6.30%+23.09%+91.59% 485B
+3.80%+3.83%+71.96%+41.69% 350B
+3.09%+6.03%+27.85%+45.42% 345B
+2.82%+4.68%+17.38%+40.15% 272B
+3.40%+2.86%-3.33%+12.08% 244B
+3.21%+5.84%+45.73%+49.99% 223B
+3.80%+6.45%+29.89%+97.73% 183B
Average +3.15%+1.75%+26.38%+50.52% 374.29B
Weighted average by Cap. +3.41%+2.31%+36.02%+68.68%

Financials

2024 2025
Net sales 507B 378M 340M 317M 287M 540M 35.97B 543M 3.81B 1.49B 18.67B 1.42B 1.39B 60.05B 535B 399M 358M 335M 303M 569M 37.94B 573M 4.01B 1.57B 19.69B 1.5B 1.46B 63.34B
Net income -52.56B -39.16M -35.21M -32.86M -29.78M -55.92M -3.73B -56.26M -394M -154M -1.93B -147M -144M -6.22B -2.15B -1.6M -1.44M -1.35M -1.22M -2.29M -153M -2.3M -16.15M -6.31M -79.23M -6.02M -5.89M -255M
Net Debt 317B 236M 213M 198M 180M 338M 22.5B 340M 2.38B 930M 11.68B 888M 869M 37.56B 351B 261M 235M 219M 199M 373M 24.85B 375M 2.63B 1.03B 12.9B 980M 959M 41.49B
Projected Income Statement - Annual - HANDOK Inc.
Logo HANDOK Inc.
Handok Inc is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through four segments. The Pharmaceutical segment mainly manufactures and sells prescription and over-the-counter drugs, including treatments for diabetes, hypertension, kidney diseases, respiratory diseases, central nervous system disorders, rare diseases, as well as anticancer drugs. The Medical Device segment mainly sells medical devices and diagnostic reagents. The Contract Manufacturing segment mainly provides contract manufacturing and quality control services for pharmaceuticals. The Real Estate Leasing segment mainly engages in the real estate leasing business.
Employees
910
Date Price Change Volume
14/10/26 ₩8,310.00 +1.84% 4,885
13/10/26 ₩8,160.00 -1.57% 3,503
12/10/26 ₩8,290.00 -3.60% 2,311
08/10/26 ₩8,600.00 -0.58% 2,592
07/10/26 ₩8,650.00 +1.41% 11,168
  1. Stock Market
  2. Stocks
  3. A002390 Stock